DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Crop Life Science Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·2 Oct 2026, 5:31 am

Crop Life Science

Crop Life Science Limited has informed the stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance is a standard requirement for companies listed on Indian bourses to ensure they adhere to the rules governing shareholding patterns and dematerialization processes.

For investors, this development is a routine administrative update rather than a significant market event. It confirms the company's adherence to corporate governance norms, which helps maintain transparency in the market. As the stock is currently trading in the small-cap category, such filings are monitored to ensure the company continues to meet all regulatory obligations.

Investors should view this as a non-event. There are no new operational details or financial implications attached to this filing. Moving forward, the focus should remain on the company's core business performance and any future announcements regarding its expansion or product launches.